Yair Feld

CorAssist Cardiovascular Ltd. develops therapeutic products for treating diastolic heart failure. Its proprietary technology enables the implantation of a device that directly improves cardiac diastolic function. The firm’s product, the ImCardia, is an elastic self-expanding device that is attached to the external left ventricular surface, through a simple off-pump closed heart procedure. The company was founded by Yair Feld, Yotam Reisner and Shay Dubi in 2003 and is headquartered in Haifa, Israel.

GeneGrafts Ltd. develops proprietary technology for modulating excitable tissues. Its technology is used for the treatment of cardiac arrhythmias, Parkinson's disease and other neurological disorders. The company was founded by Yair Feld, Lior Gepstein, Shimon Marom and Meira Melamed Frank in 2003 and is headquartered in Haifa, Israel.

ProArc Medical Ltd. develops a prostatic device clearing. The firm offers ClearRing product. The company was founded by Yair Feld in August 2010 and is headquartered in Caesarea, Israel.

Paragate Medical Ltd. engages in the development of implantable device for the treatment of fluid overload in patients suffering from chronic heart or kidney failure. The company was founded by Nitai Hanani and Yair Feld in 2016 and is headquartered in Haifa, Israel.

Nephera Ltd. develops products to protect the kidneys via neuro-hormonal modulation. Its technology is based on electrical stimulation of the urinary bladder in order to improve renal function using natural mechanisms. The firm's product RenaSense, which is a medical device that improves and maintains kidney functionality in patients suffering from decompensate heart failure. The company was founded by Gill Bar-Yoseph and Yair Feld in 2008 and is headquartered in Caesarea, Israel.